drugset / Trial / NCT01812564

Use of Platelet Rich Plasma in the Management of Acute Hamstring Muscle Strain Injury

NCT01812564

Phase 2 Completed 90 enrolled Aspetar
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the therapeutic benefit of utilizing complex growth factor preparations (Platelet Rich Plasma (PRP) in the management of acute hamstring injuries. The hypothesis is that the time to return to sport is shorter in the patient group treated with Complex Growth Factor Preparations (PRP) in combination with exercise therapy in comparison with 2 control groups: * the patient group treated with Platelet Poor Plasma (PPP) injections in combination with exercise therapy (control injection AND usual care). * the patient group treated with exercise therapy (usual care)

Timeline

Start
2009-11
Primary completion
2013-10
Completion
2014-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Platelet Rich Plasma Other / unclassified 1 ml Other

Indications

No indication recorded.